|
|||||
|
|
Tibolone histology of the endometrium and breast endpoints study: design of the trial and endometrial histology at baseline in postmenopausal women |
|
| Authors: | Archer David F,Hendrix Susan,Ferenczy Alex,Felix Juan,Gallagher J Chris,Rymer Janice,Skouby Sven O,den Hollander Wil,Stathopoulos Victoria,Helmond Frans A THEBES Study Group |
| Affiliation: | a Department of Obstetrics and Gynecology, Contraceptive Research and Development Program Clinical Research Center, Eastern Virginia Medical School, Norfolk, Virginia b Wayne State University/Hutzel Women's Hospital, Detroit, Michigan c McGill University and Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Quebec, Canada d Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California e Bone Metabolism Section, Creighton University Medical Center, Omaha, Nebraska f King's College School of Medicine at Guy's and St. Thomas' Hospitals, Division of Obstetrics and Gynaecology, London, United Kingdom g Department of Obstetrics and Gynecology, Frederiksberg Hospital, Copenhagen, Denmark h NV Organon, Oss, the Netherlands i Organon International, Roseland, New Jersey |
| Abstract: | |
| Keywords: | Tibolone hormone therapy endometrial safety endometrial histology endometrial hyperplasia endometrial cancer breast tenderness vaginal bleeding estrogen progestin |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |